STI
47
-12
HON
65
-2
DAL
80
-4
DHI
48
3
BMY
53
-7
DG
2
-6
COST
58
-2
MAS
51
4
AXP
66
2
ORLY
53
-3
FOXA
55
9
HSIC
54
-3
KMX
58
3
ETR
68
3
MPC
47
3
EQR
54
-2
KR
34
-3
NOV
58
3
DD
56
3
XYL
37
2
STI
47
-12
HON
65
-2
DAL
80
-4
DHI
48
3
BMY
53
-7
DG
2
-6
COST
58
-2
MAS
51
4
AXP
66
2
ORLY
53
-3
FOXA
55
9
HSIC
54
-3
KMX
58
3
ETR
68
3
MPC
47
3
EQR
54
-2
KR
34
-3
NOV
58
3
DD
56
3
XYL
37
2
Financhill
Back

Embecta Vs. Protalix BioTherapeutics Industry Stock Comparison

Buy
51

EMBC
Embecta

Last Price:
13.86
Seasonality Move:
-7.26%
Buy
80

PLX
Protalix BioTherapeutics

Last Price:
1.70
Seasonality Move:
78.33%
Buy
51
Embecta (EMBC) is a Buy

Is Embecta a Buy, Sell or Hold?

  • The current Embecta [EMBC] share price is $13.61. The Score for EMBC is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • EMBC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Protalix BioTherapeutics (PLX) is a Buy

Is Protalix BioTherapeutics a Buy, Sell or Hold?

  • The current Protalix BioTherapeutics [PLX] share price is $1.69. The Score for PLX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • PLX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EMBC Stock Price Chart

What is Embecta's stock price today?

  • The Embecta share price today is $13.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EMBC is experiencing slight buying pressure.

PLX Stock Price Chart

What is Protalix BioTherapeutics's stock price today?

  • The Protalix BioTherapeutics share price today is $1.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing slight buying pressure.

EMBC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 40.3 Sell
Chaikin Money Flow: 119745 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.79 - 15.29) Sell
Bollinger Bands (100): (13.19 - 15.63) Sell

PLX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 76 Buy
Chaikin Money Flow: 188555 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.05 - 1.43) Buy
Bollinger Bands (100): (0.96 - 1.24) Buy

EMBC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.74 Sell
20-day SMA: 14.69 Sell
50-day SMA: 14.5 Sell
200-day SMA: 13.65 Sell
8-day EMA: 14.41 Sell
20-day EMA: 14.56 Sell
50-day EMA: 14.48 Sell
200-day EMA: 14.78 Sell

PLX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.44 Buy
20-day SMA: 1.28 Buy
50-day SMA: 1.15 Buy
200-day SMA: 1.19 Buy
8-day EMA: 1.49 Buy
20-day EMA: 1.33 Buy
50-day EMA: 1.2 Buy
200-day EMA: 1.22 Buy

Embecta Earnings Growth & EMBC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.41 per share, and a decrease next year of $0.12 per share.

Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Embecta Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Protalix BioTherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):